Data as of Dec 05
| +0.24 / +5.90%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +190.02% increase from the last price of 4.31.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.